{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:35:49Z","timestamp":1788478549410,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Allergy and Infectious Diseases Emerging Leaders in Data Science Research Program"},{"name":"Division of Intramural Research, National Heart Lung and Blood Institute"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bronchiectasis is a chronic lung condition frequently associated with nontuberculous mycobacteria pulmonary (NTM) disease. Persons with these conditions are at increased risk of mortality. Patient reported outcome (PRO) instruments and the 6-minute walk test (6MWT) have been shown to predict mortality for several lung conditions, but these measures have not been fully evaluated for bronchiectasis and NTM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a retrospective cohort study among adult patients enrolled in a natural history study of bronchiectasis at the National Heart, Lung, and Blood Institute. Electronic medical records were queried for demographic, clinical, microbiologic, radiographic, and PRO instrument data: St. George\u2019s Respiratory Questionnaire (SGRQ), Medical Research Council Dyspnea Scale, and the Pulmonary Symptom Severity Score (PSSS). The study baseline date was defined as the patient\u2019s first visit after January 1st, 2015 with a SGRQ or 6MWT completed. Follow-up was defined as the interval between the study baseline visit and date of death or December 31st, 2019. Sex-stratified Cox proportional-hazards regression was conducted to identify predictors of mortality. Separate models were run for each PRO and 6MWT measure, controlling for age, body mass index (BMI), fibrocavitary disease status, and <jats:italic>M. abscessus<\/jats:italic> infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In multivariable Cox proportional-hazards regression models, the PSSS-severity (aHR 1.29, 95% CI 1.04\u20131.59), the 6MWT total distance walked (aHR 0.938, 95% CI 0.896\u20130.981) and distance saturation product (aHR 0.930, 95% CI 0.887\u20130.974) independently predicted mortality. In addition, BMI was significantly predictive of mortality in all models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The 6MWT and a PRO instrument capturing symptom severity are independently predictive of mortality in our cohort of bronchiectasis patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07054-6","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T17:03:22Z","timestamp":1642784602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort"],"prefix":"10.1186","volume":"22","author":[{"given":"Rebekah A.","family":"Blakney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Ricotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Drew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa N.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chevalia","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth N.","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Fennelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Rebecca","family":"Prevots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"7054_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12931-019-1243-3","volume":"20","author":"S Sin","year":"2019","unstructured":"Sin S, Yun SY, Kim JM, Park CM, Cho J, Choi SM, Lee J, Park YS, Lee SM, Yoo CG, Kim YW, Han SK, Lee CH. Mortality risk and causes of death in patients with non-cystic fibrosis bronchiectasis. Respir Res. 2019;20:271.","journal-title":"Respir Res"},{"key":"7054_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","volume":"185","author":"J Adjemian","year":"2012","unstructured":"Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012;185:881\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"7054_CR3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3201\/eid2303.161927","volume":"23","author":"TK Marras","year":"2017","unstructured":"Marras TK, Campitelli MA, Lu H, Chung H, Brode SK, Marchand-Austin A, Winthrop KL, Gershon AS, Kwong JC, Jamieson FB. Pulmonary nontuberculous mycobacteria-associated deaths, Ontario, Canada, 2001\u20132013. Emerg Infect Dis. 2017;23:468\u201376.","journal-title":"Emerg Infect Dis"},{"key":"7054_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.rmed.2018.10.022","volume":"145","author":"TK Marras","year":"2018","unstructured":"Marras TK, Vinnard C, Zhang Q, Hamilton K, Adjemian J, Eagle G, Zhang R, Chou E, Olivier KN. Relative risk of all-cause mortality in patients with nontuberculous mycobacterial lung disease in a US managed care population. Respir Med. 2018;145:80\u20138.","journal-title":"Respir Med"},{"key":"7054_CR5","doi-asserted-by":"publisher","first-page":"e0197976","DOI":"10.1371\/journal.pone.0197976","volume":"13","author":"MM Jones","year":"2018","unstructured":"Jones MM, Winthrop KL, Nelson SD, Duvall SL, Patterson OV, Nechodom KE, Findley KE, Radonovich LJ, Samore MH, Fennelly KP. Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration. PLoS ONE. 2018;13:e0197976.","journal-title":"PLoS ONE"},{"key":"7054_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12879-018-3113-x","volume":"18","author":"R Diel","year":"2018","unstructured":"Diel R, Lipman M, Hoefsloot W. High mortality in patients with Mycobacterium avium complex lung disease: a systematic review. BMC Infect Dis. 2018;18:206.","journal-title":"BMC Infect Dis"},{"key":"7054_CR7","first-page":"CD34","volume":"11","author":"MS Karanth","year":"2017","unstructured":"Karanth MS, Awad NT. Six minute walk test: a tool for predicting mortality in chronic pulmonary diseases. J Clin Diagn Res. 2017;11:CD34\u20138.","journal-title":"J Clin Diagn Res"},{"key":"7054_CR8","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.rmed.2006.02.004","volume":"100","author":"CJ Lettieri","year":"2006","unstructured":"Lettieri CJ, Nathan SD, Browning RF, Barnett SD, Ahmad S, Shorr AF. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med. 2006;100:1734\u201341.","journal-title":"Respir Med"},{"key":"7054_CR9","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.rmed.2008.11.005","volume":"103","author":"AL Lee","year":"2009","unstructured":"Lee AL, Button BM, Ellis S, Stirling R, Wilson JW, Holland AE, Denehy L. Clinical determinants of the 6-Minute Walk Test in bronchiectasis. Respir Med. 2009;103:780\u20135.","journal-title":"Respir Med"},{"key":"7054_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12890-018-0686-5","volume":"18","author":"K Yagi","year":"2018","unstructured":"Yagi K, Asakura T, Namkoong H, Suzuki S, Asami T, Okamori S, Kusumoto T, Funatsu Y, Kamata H, Nishimura T, Ishii M, Betsuyaku T, Hasegawa N. Association between six-minute walk test parameters and the health-related quality of life in patients with pulmonary Mycobacterium avium complex disease. BMC Pulm Med. 2018;18:114.","journal-title":"BMC Pulm Med"},{"key":"7054_CR11","unstructured":"FDA U. Food and Drug Administration. The Voice of the Patient. Non-Tuberculous Mycobacterial (NTM) Lung Infection Public Meeting: October 15, 2015. 2016."},{"key":"7054_CR12","unstructured":"US Food and Drug Administration. Guidance for Industry: Patient-reported outcome measures: Use in medical product development to support labeling claims 2009."},{"key":"7054_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1440-1843.2008.01441.x","volume":"14","author":"R Antonelli-Incalzi","year":"2009","unstructured":"Antonelli-Incalzi R, Pedone C, Scarlata S, Battaglia S, Scichilone N, Forestiere F, Bellia V. Correlates of mortality in elderly COPD patients: focus on health-related quality of life. Respirology (Carlton, VIC). 2009;14:98\u2013104.","journal-title":"Respirology (Carlton, VIC)"},{"key":"7054_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1164\/ajrccm.156.2.9607083","volume":"156","author":"CB Wilson","year":"1997","unstructured":"Wilson CB, Jones PW, O\u2019Leary CJ, Cole PJ, Wilson R. Validation of the St. George\u2019s Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med. 1997;156:536\u201341.","journal-title":"Am J Respir Crit Care Med"},{"key":"7054_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/bmj.2.5147.257","volume":"2","author":"CM Fletcher","year":"1959","unstructured":"Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2:257\u201366.","journal-title":"Br Med J"},{"key":"7054_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.54.7.581","volume":"54","author":"JC Bestall","year":"1999","unstructured":"Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581\u20136.","journal-title":"Thorax"},{"key":"7054_CR17","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1378\/chest.121.5.1434","volume":"121","author":"K Nishimura","year":"2002","unstructured":"Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434\u201340.","journal-title":"Chest"},{"key":"7054_CR18","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/0959-8049(94)90182-1","volume":"30","author":"RK Portenoy","year":"1994","unstructured":"Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer (Oxford, England: 1990). 1994;30:1326\u201336.","journal-title":"Eur J Cancer (Oxford, England: 1990)"},{"key":"7054_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/crj.12127","volume":"9","author":"M Y\u00fcceege","year":"2015","unstructured":"Y\u00fcceege M, Saniso\u011flu B, F\u0131rat H, Ersoy Y, Sevgi E, Kurt EB. The clinical utility of Memorial Symptom Assessment-Short Form and Condensed Memorial Symptom Assessment Scale in Turkish lung cancer patients. Clin Respir J. 2015;9:221\u20137.","journal-title":"Clin Respir J"},{"key":"7054_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jpainsymman.2008.07.006","volume":"38","author":"CD Blinderman","year":"2009","unstructured":"Blinderman CD, Homel P, Billings JA, Tennstedt S, Portenoy RK. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage. 2009;38:115\u201323.","journal-title":"J Pain Symptom Manage"},{"key":"7054_CR21","doi-asserted-by":"crossref","unstructured":"ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111\u2013117.","DOI":"10.1164\/ajrccm.166.1.at1102"},{"key":"7054_CR22","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1164\/ajrccm.158.5.9710086","volume":"158","author":"PL Enright","year":"1998","unstructured":"Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158:1384\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"7054_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/jep.12629","volume":"23","author":"RW Bohannon","year":"2017","unstructured":"Bohannon RW, Crouch R. Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review. J Eval Clin Pract. 2017;23:377\u201381.","journal-title":"J Eval Clin Pract"},{"key":"7054_CR24","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1183\/09031936.00150414","volume":"44","author":"SJ Singh","year":"2014","unstructured":"Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, Lee AL, Camillo CA, Troosters T, Spruit MA, Carlin BW, Wanger J, Pepin V, Saey D, Pitta F, Kaminsky DA, McCormack MC, MacIntyre N, Culver BH, Sciurba FC, Revill SM, Delafosse V, Holland AE. An official systematic review of the European Respiratory Society\/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44:1447\u201378.","journal-title":"Eur Respir J"},{"key":"7054_CR25","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3109\/09593980802664711","volume":"25","author":"S Jenkins","year":"2009","unstructured":"Jenkins S, Cecins N, Camarri B, Williams C, Thompson P, Eastwood P. Regression equations to predict 6-minute walk distance in middle-aged and elderly adults. Physiother Theory Pract. 2009;25:516\u201322.","journal-title":"Physiother Theory Pract"},{"key":"7054_CR26","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.rmed.2014.07.006","volume":"108","author":"AL Lee","year":"2014","unstructured":"Lee AL, Hill CJ, Cecins N, Jenkins S, McDonald CF, Burge AT, Rautela L, Stirling RG, Thompson PJ, Holland AE. Minimal important difference in field walking tests in non-cystic fibrosis bronchiectasis following exercise training. Respir Med. 2014;108:1303\u20139.","journal-title":"Respir Med"},{"key":"7054_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1164\/rccm.201209-1596OC","volume":"187","author":"MI Polkey","year":"2013","unstructured":"Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agust\u00ed A, Bakke PS, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Miller BE, Crim C, Yates J, Wouters EF, Celli B. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med. 2013;187:382\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"7054_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0954-6111(06)80166-6","volume":"85","author":"PW Jones","year":"1991","unstructured":"Jones PW, Quirk FH, Baveystock CM. The St George\u2019s Respiratory Questionnaire. Respir Med. 1991;85:25\u201331.","journal-title":"Respir Med"},{"key":"7054_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1183\/09031936.02.00213202","volume":"19","author":"M Ferrer","year":"2002","unstructured":"Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, Masa JF, Viejo JL, Jim\u00e9nez-Ruiz CA, Miravitlles M. Interpretation of quality of life scores from the St George\u2019s Respiratory Questionnaire. Eur Respir J. 2002;19:405\u201313.","journal-title":"Eur Respir J"},{"key":"7054_CR30","doi-asserted-by":"publisher","first-page":"582","DOI":"10.5588\/ijtld.15.0807","volume":"20","author":"M Fleshner","year":"2016","unstructured":"Fleshner M, Olivier KN, Shaw PA, Adjemian J, Strollo S, Claypool RJ, Folio L, Zelazny A, Holland SM, Prevots DR. Mortality among patients with pulmonary non-tuberculous mycobacteria disease. Int J Tuberc Lung Dis. 2016;20:582\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"7054_CR31","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.21037\/jtd.2017.08.53","volume":"9","author":"M-H Hsieh","year":"2017","unstructured":"Hsieh M-H, Fang Y-F, Chung F-T, Lee C-S, Chang Y-C, Liu Y-Z, Wu C-H, Lin H-C. Distance-saturation product of the 6-minute walk test predicts mortality of patients with non-cystic fibrosis bronchiectasis. J Thorac Dis. 2017;9:3168\u201376.","journal-title":"J Thorac Dis"},{"key":"7054_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jama.2010.1923","volume":"305","author":"S Studenski","year":"2011","unstructured":"Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J. Gait speed and survival in older adults. JAMA. 2011;305:50\u20138.","journal-title":"JAMA"},{"key":"7054_CR33","doi-asserted-by":"publisher","first-page":"106515","DOI":"10.1016\/j.rmed.2021.106515","volume":"185","author":"T Ogawa","year":"2021","unstructured":"Ogawa T, Asakura T, Suzuki S, Okamori S, Kusumoto T, Sato Y, Namkoong H, Kamata H, Ishii M, Fukunaga K, Hasegawa N. Longitudinal validity and prognostic significance of the St George\u2019s Respiratory Questionnaire in Mycobacterium avium complex pulmonary disease. Respir Med. 2021;185:106515.","journal-title":"Respir Med"},{"key":"7054_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.01300-2019","volume":"55","author":"E Henkle","year":"2020","unstructured":"Henkle E, Winthrop KL, Ranches GP, Plinke W, Litvin HK, Quittner AL. Preliminary validation of the NTM Module: a patient-reported outcome measure for patients with pulmonary nontuberculous mycobacterial disease. Eur Respir J. 2020;55:1.","journal-title":"Eur Respir J"},{"key":"7054_CR35","first-page":"390","volume":"7","author":"KA Despotes","year":"2020","unstructured":"Despotes KA, Choate R, Addrizzo-Harris D, Aksamit TR, Barker A, Basavaraj A, Daley CL, Eden E, DiMango A, Fennelly K, Philley J, Johnson MM, McShane PJ, Metersky ML, O\u2019Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Winthrop KL, Knowles MR, Daniels MLA, Noone PG. Nutrition and markers of disease severity in patients with bronchiectasis. Chronic Obstr Pulm Dis. 2020;7:390\u2013403.","journal-title":"Chronic Obstr Pulm Dis"},{"key":"7054_CR36","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1111\/1440-1681.13331","volume":"47","author":"L Li","year":"2020","unstructured":"Li L, Li Z, Bi J, Li H, Wang S, Shao C, Song Y. The association between serum albumin\/prealbumin level and disease severity in non-CF bronchiectasis. Clin Exp Pharmacol Physiol. 2020;47:1537\u201344.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"7054_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1183\/13993003.00454-2020","volume":"57","author":"JH Song","year":"2021","unstructured":"Song JH, Kim BS, Kwak N, Han K, Yim JJ. Impact of body mass index on development of nontuberculous mycobacterial pulmonary disease. Eur Respir J. 2021;57:2.","journal-title":"Eur Respir J"},{"key":"7054_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10096-020-04026-z","volume":"40","author":"K Fujiwara","year":"2020","unstructured":"Fujiwara K, Furuuchi K, Aono A, Uesugi F, Shirai T, Nakamoto K, Shimada T, Mochizuki F, Tanaka Y, Iijima H, Yoshiyama T, Shiraishi Y, Kurashima A, Ohta K, Mitarai S, Morimoto K. Clinical risk factors related to treatment failure in Mycobacterium abscessus lung disease. Eur J Clin Microbiol Infect Dis. 2020;40:247\u201352.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"7054_CR39","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.21037\/jtd-20-803","volume":"12","author":"Y Hachisu","year":"2020","unstructured":"Hachisu Y, Murata K, Takei K, Tsuchiya T, Tsurumaki H, Koga Y, Horie T, Takise A, Hisada T. Prognostic nutritional index as a predictor of mortality in nontuberculous mycobacterial lung disease. J Thorac Dis. 2020;12:3101\u20139.","journal-title":"J Thorac Dis"},{"key":"7054_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1164\/rccm.202004-1418OC","volume":"203","author":"HJ Kim","year":"2021","unstructured":"Kim HJ, Kwak N, Hong H, Kang N, Im Y, Jhun BW, Yim JJ. BACES Score for predicting mortality in nontuberculous mycobacterial pulmonary disease. Am J Respir Crit Care Med. 2021;203:230\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"7054_CR41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1378\/chest.121.1.220","volume":"121","author":"JL Abrahm","year":"2002","unstructured":"Abrahm JL, Hansen-Flaschen J. Hospice care for patients with advanced lung disease. Chest. 2002;121:220\u20139.","journal-title":"Chest"},{"key":"7054_CR42","first-page":"90","volume":"49","author":"J Hansen-Flaschen","year":"2004","unstructured":"Hansen-Flaschen J. Chronic obstructive pulmonary disease: the last year of life. Respir Care. 2004;49:90\u20137.","journal-title":"Respir Care"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07054-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T17:03:34Z","timestamp":1642784614000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07054-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7054"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07054-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the National Institutes of Health Institutional Review Board ( identifier NCT00943514). All participants provided written informed consent and all methods were carried out in accordance with relevant ethics guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}